WallStSmart
MESO

Mesoblast Ltd

NASDAQ: MESO · HEALTHCARE · BIOTECHNOLOGY

$15.55
+2.17% today

Updated 2026-04-29

Market cap
$2.01B
P/E ratio
P/S ratio
30.75x
EPS (TTM)
$-0.74
Dividend yield
52W range
$10 – $22
Volume
0.3M

Mesoblast Ltd (MESO) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Revenue$2.82M$1.68M$909807.00$890708.00$5500.00$120.92M$38.28M$28.79M$25.98M$23.75M$42.55M$2.41M$17.34M$16.72M$32.16M$7.46M$10.21M$7.50M$5.90M$17.20M
Revenue growth (YoY)-40.5%-45.8%-2.1%-99.4%+2198468.8%-68.3%-24.8%-9.7%-8.6%+79.2%-94.3%+618.9%-3.6%+92.3%-76.8%+37.0%-26.5%-21.3%+191.4%
Cost of revenue$21.27M$25.43M$23.78M$29.76M$12.06M$5.51M$75.17M$81.50M$85.73M$63.57M$54.92M$41.07M$5.13M
Gross profit$2.82M$1.68M$909807.00$890708.00$5500.00$120.92M$38.28M$7.52M$546000.00$-35000.00$12.79M$-9.65M$11.83M$-58.45M$-49.34M$-78.28M$-53.36M$-47.42M$-35.17M$12.07M
Gross margin100.0%100.0%100.0%100.0%100.0%100.0%100.0%26.1%2.1%-0.1%30.0%-400.2%68.2%-349.5%-153.4%-1049.8%-522.6%-632.2%-595.9%70.2%
R&D$5.36M$4.58M$6.21M$7.15M$7.57M$15.31M$36.94M$43.11M$55.30M$77.59M$50.01M$58.91M$65.93M$59.81M$56.19M$53.01M$32.81M$27.19M$25.35M$34.81M
SG&A$3.75M$4.11M$2.64M$3.17M$3.57M$11.84M$28.05M$30.73M$26.56M$36.17M$22.50M$23.01M$21.91M$21.63M$25.61M$30.87M$27.21M$25.37M$23.63M$23.21M
Operating income$-6.28M$-7.01M$-7.94M$-9.43M$-10.39M$93.76M$-48.72M$-60.08M$-72.38M$-113.39M$-55.89M$-90.04M$-77.34M$-80.20M$-74.87M$-109.10M$-80.57M$-69.29M$-84.15M$-62.44M
Operating margin-222.7%-417.6%-872.7%-1058.6%-188851.8%77.5%-127.3%-208.7%-278.6%-477.5%-131.4%-3733.1%-446.0%-479.6%-232.8%-1463.2%-789.1%-923.7%-1425.7%-363.1%
EBITDA$-8.14M$-6.95M$-7.78M$-9.31M$-10.97M$92.44M$-48.34M$-59.31M$-67.01M$-90.19M$-28.07M$-87.16M$-74.69M$-84.53M$-68.97M$-84.65M$-76.57M$-58.55M$-56.08M$-73.66M
EBITDA margin-288.6%-413.9%-855.4%-1045.1%-199515.4%76.4%-126.3%-206.0%-257.9%-379.8%-66.0%-3613.5%-430.7%-505.5%-214.5%-1135.4%-749.9%-780.6%-950.1%-428.3%
EBIT$-8.19M$-7.01M$-7.94M$-9.43M$-11.13M$92.26M$-48.72M$-60.08M$-68.13M$-92.15M$-30.27M$-90.22M$-77.34M$-86.67M$-72.64M$-88.92M$-80.95M$-62.66M$-57.97M$-80.06M
Interest expense$110092.00$542.00$0.00$0.00$0.00$14912.00$289.00$0.00$4.33M$10.53M$9.31M$0.00$1.83M$11.70M$14.72M$10.71M$17.29M$19.44M$20.66M$22.93M
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-8.30M$-8.73M$-10.06M$-12.29M$-14.78M$90.61M$-71.15M$-61.66M$-80.96M$-119.37M$-4.13M$-76.81M$-35.29M$-89.80M$-77.94M$-98.81M$-91.35M$-81.89M$-87.96M$-102.14M
Net income growth (YoY)-5.2%-15.3%-22.1%-20.3%+713.0%-178.5%+13.3%-31.3%-47.4%+96.5%-1761.3%+54.1%-154.5%+13.2%-26.8%+7.6%+10.4%-7.4%-16.1%
Profit margin-294.1%-519.7%-1106.0%-1379.3%-268743.5%74.9%-185.9%-214.2%-311.6%-502.6%-9.7%-3184.7%-203.5%-537.0%-242.4%-1325.3%-894.6%-1091.7%-1490.3%-593.9%